1059-1069
Original Article
In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines
Steven J. Wolf, Laurence P. G. Wakelin, Zhicong He, Bernard W. Stewart and Daniel R. Catchpoole
1071-1077
Original Article
A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma
Takaki Yoshikawa, Akira Tsuburaya, Naoki Hirabayashi, Kazuhiro Yoshida and Naoki Nagata, et al.
1079-1083
Original Article
Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium
Yoshiaki Yamada, Youko Itoh, Shigeyuki Aoki, Kogenta Nakamura and Tomohiro Taki, et al.
1085-1095
Original Article
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy
Alain G. Musende, Andy Eberding, Catherine Wood, Hans Adomat and Ladan Fazli, et al.
1097-1104
Original Article
Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells
Xiao-Li Li, Chong-Zhi Wang, Sangeeta R. Mehendale, Shi Sun and Qi Wang, et al.
1105-1113
Original Article
Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974
Karen Y. Wonders, David S. Hydock, Stephanie Greufe, Carole M. Schneider and Reid Hayward
1115-1122
Original Article
Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells
Maiko Suzuki, Manabu Endo, Fumiaki Shinohara, Seishi Echigo and Hidemi Rikiishi
1123-1127
Original Article
Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
Zheng-Tao Zhou, Xin-Hua Xu, Qing Wei, Ming-qian Lu and Jie Wang, et al.
1129-1137
Original Article
Schedule-dependent synergism and antagonism between pemetrexed and docetaxel in human lung cancer cell lines in vitro
Yasuhiko Kano, Masaru Tanaka, Miyuki Akutsu, Kiyoshi Mori and Yasuo Yazawa, et al.
1139-1148
Original Article
A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer
Olivier Rixe, Sandra X. Franco, Denise A. Yardley, Stephen R. Johnston and Miguel Martin, et al.
1149-1155
Original Article
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study
Stephen I. Shibata, James H. Doroshow, Paul Frankel, Timothy W. Synold and Yun Yen, et al.
1157-1163
Original Article
Open AccessAntineoplastic activity of idazoxan hydrochloride
G. F. Eilon, L. Weisenthal, M. Stupecky, G. Landucci and L. M. Slater
1165-1172
Original Article
Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN™), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors
Noboru Yamamoto, Tomohide Tamura, Nobuyuki Yamamoto, Kazuhiko Yamada and Yasuhide Yamada, et al.
1173-1179
Original Article
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
Hui-Ju Ch’ang, Chin-Lun Huang, Hsiu-Po Wang, Her-Shyong Shiah and Ming-Chu Chang, et al.
1181-1185
Original Article
A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer
Yoshitaka Totani, Yuji Saito, Masamichi Hayashi, Toshihiko Tada and Yasuo Kohashi, et al.
1187-1194
Original Article
Open AccessExpression of Na,K-ATPase-β1 subunit increases uptake and sensitizes carcinoma cells to oxaliplatin
Ramakumar Tummala, Daniel Wolle, Sonali P. Barwe, Valerie B. Sampson and Ayyappan K. Rajasekaran, et al.
1195-1200
Original Article
Thymidylate synthetase allelic imbalance in clear cell renal carcinoma
Davide Colavito, Giuseppe Cartei, Massimo Dal Bianco, Anna Stecca and Fable Zustovich, et al.
1201-1210
Original Article
Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn
Anna Israyelyan, Edward John Shannon, Abolghasem Baghian, Michael T. Kearney and Konstantin G. Kousoulas
1211-1219
Original Article
Experimental study of combination therapy with S-1 against pancreatic cancer
Jun Yoshizawa, Asako Takizawa, Osamu Takeuchi, Osamu Hiraku and Ken Sasaki, et al.
1221-1233
Original Article
Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1α in Ehrlich ascites tumor cells
Akhilesh Kumar, Saritha S. D’Souza, Sachin Raj Mysore Nagaraj, S. L. Gaonkar and Bharathi P. Salimath, et al.
1235-1251
Original Article
Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition
Giampietro Viola, Laura Cecconet, Anna Leszl, Giuseppe Basso and Paola Brun, et al.
1253-1259
Original Article
Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma
Michele Reni, S. Cereda, G. Balzano, P. Passoni and A. Rognone, et al.
1261-1268
Original Article
Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice
Timothy H. Marczylo, Darren Cooke, Karen Brown, William P. Steward and Andreas J. Gescher